Zoetis Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zoetis Inc (ZTS)Zoetis Inc stock price live, this page displays NYSE ZTS stock exchange data. View the ZTS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zoetis Inc real time stock price chart below.
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 174.53.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 174.53.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
174.53
-0.79(-0.45%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
173.73
176.53
52 wk Range
144.80
201.92
ZTS Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
173.73176.53
52 wk Range
144.80201.92
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(0.99%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(0.99%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockZTS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
214.80
Upside
+23.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 12 consecutive years
- Zoetis Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zoetis reshapes leadership for global growth
- Investing.com
Zoetis Inc Company Profile
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Zoetis Inc SWOT Analysis
Market Leadership | Zoetis maintains dominance in animal health, with a robust portfolio spanning companion animal and livestock sectors, despite increasing competition |
Financial Resilience | Analysts project continued growth, with Q3 2024 organic revenue expected to rise 9.2%. Price targets range from $225 to $242, reflecting positive outlook |
Product Innovation | Explore Zoetis's key growth drivers, including Librela for canine osteoarthritis and Apoquel for dermatology, alongside a promising pipeline in oncology and cardiology |
Future Prospects | Delve into Zoetis's strategies for tapping untapped markets in animal anti-depressants and pain management, while navigating challenges like foreign exchange impacts |
ZTS Full Pro Research
Institutional-Grade Stock Analysis
Understand how ZTS earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Zoetis Inc Earnings Call Summary for Q3/2024
- Zoetis reports 11% operational revenue growth and 18% operational growth in adjusted net income for Q2 2024
- Strong demand for osteoarthritis pain franchise, with Librela and Solensia seeing substantial operational revenue growth
- Company raises 2024 revenue guidance to $9.1-$9.25 billion, adjusted net income expected between $2.64-$2.69 billion
- Announces $6 billion share repurchase program following record $533 million in share repurchases
- US revenue grew 12%, with companion animal sector up 13% and livestock 11%; international revenue up 10% excluding forex impact
Last Updated: 2024-08-07, 05:42 a/m
Read Full TranscriptCompare ZTS to Peers and Sector
Metrics to compare | ZTS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZTSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.4x | −4.4x | −0.7x | |
PEG Ratio | 3.89 | 0.02 | 0.00 | |
Price/Book | 15.0x | 1.0x | 2.6x | |
Price / LTM Sales | 8.6x | 1.0x | 3.2x | |
Upside (Analyst Target) | 22.3% | 43.2% | 45.9% | |
Fair Value Upside | Unlock | 17.6% | 7.6% | Unlock |
Analysts' Recommendations
15 Buy
4 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 214.80
(+23.07% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.33
Dividend Yield
0.99%
Industry Median 1.74%
Annualized payout
1.7280
Paid quarterly
5-Years Growth
+22.01%
Growth Streak
People Also Watch
FAQ
What Is the Zoetis Inc (ZTS) Stock Price Today?
The Zoetis Inc stock price today is 174.53
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
Does Zoetis Inc Pay Dividends? What’s The Current Dividend Yield?
The Zoetis Inc dividend yield is 0.99%.
What Is the Zoetis Inc Market Cap?
As of today, Zoetis Inc market cap is 78.59B.
What is Zoetis Inc Earnings Per Share?
The Zoetis Inc EPS is 5.33.
What Is the Next Zoetis Inc Earnings Date?
Zoetis Inc will release its next earnings report on Feb 18, 2025.
From a Technical Analysis Perspective, Is ZTS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.